BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12481542)

  • 21. Coming to grips with bone loss.
    Marx J
    Science; 2004 Sep; 305(5689):1420-2. PubMed ID: 15353792
    [No Abstract]   [Full Text] [Related]  

  • 22. Parathyroid hormone and bone healing.
    Ellegaard M; Jørgensen NR; Schwarz P
    Calcif Tissue Int; 2010 Jul; 87(1):1-13. PubMed ID: 20428858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstructing the skeleton with intermittent parathyroid hormone.
    Seeman E; Delmas PD
    Trends Endocrinol Metab; 2001 Sep; 12(7):281-3. PubMed ID: 11504661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
    Whitfield JF; Morley P
    Trends Pharmacol Sci; 1995 Nov; 16(11):382-6. PubMed ID: 8578607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Building bone to reverse osteoporosis and repair fractures.
    Khosla S; Westendorf JJ; Oursler MJ
    J Clin Invest; 2008 Feb; 118(2):421-8. PubMed ID: 18246192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health.
    Indran IR; Liang RL; Min TE; Yong EL
    Pharmacol Ther; 2016 Jun; 162():188-205. PubMed ID: 26820757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis.
    Lyritis GP; Georgoulas T; Zafeiris CP
    Ann N Y Acad Sci; 2010 Sep; 1205():277-83. PubMed ID: 20840284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.
    Suzuki A; Sekiguchi S; Asano S; Itoh M
    J Pharmacol Sci; 2008 Apr; 106(4):530-5. PubMed ID: 18431035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone in the treatment of osteoporosis.
    Fujita T
    BioDrugs; 2001; 15(11):721-8. PubMed ID: 11707147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid hormone and leptin--new peptides, expanding clinical prospects.
    Whitfield JF
    Expert Opin Investig Drugs; 2005 Mar; 14(3):251-64. PubMed ID: 15833057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    Riggs BL; Khosla S; Melton LJ
    J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and management of primary osteoporosis.
    Bauwens SF; Drinka PJ; Boh LE
    Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical disorders of bone resorption.
    Russell G; Mueller G; Shipman C; Croucher P
    Novartis Found Symp; 2001; 232():251-67; discussion 267-71. PubMed ID: 11277085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of osteoporosis treatment - a research update.
    Lippuner K
    Swiss Med Wkly; 2012; 142():w13624. PubMed ID: 22815185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The concept and treatment of osteoporosis.
    Rittinghaus EF; Hesch RD; Harms HM; Busch U; Prokop M; Delling G
    Exp Gerontol; 1990; 25(3-4):357-65. PubMed ID: 2226671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
    Marie PJ; Kassem M
    Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.